Phase 1 HER2-Positive Solid Tumor Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor

HER2-Positive Solid Tumor

Yuhan Corporation147 enrolled19 locationsNCT05523947

Recruiting

Phase 1

A Phase 1/1b Study of IAM1363 in HER2 Cancers

HER2-positive Breast CancerHER2 + Breast CancerHER2 Mutation-Related Tumors+10 more

Iambic Therapeutics, Inc383 enrolled53 locationsNCT06253871

Recruiting

Phase 1

A Study of VRN101099 in Patients With HER2-Positive Solid Tumors

HER2-Positive Solid Tumors

Voronoi, Inc72 enrolled1 locationNCT06806982